Medicomp is a name synonymous with remote patient monitoring.
“We’ve been in business for 37 years, so we have a vibrant history of working with clinicians and patients,” stated Tony Balda, President and CEO of Medicomp.
One of Medicomp’s recent game-changing technologies is TelePatchTM, a completely wireless ambulatory cardiac monitor with the highest clinical yield in the industry.
The Florida-based firm provides some of the most reliable and sophisticated monitoring technologies in the world. These technologies are crafted and developed in-house within the company’s R&D division. The new TelePatch, combined with the company’s proprietary machine learning ECG algorithm, has improved the patient user experience allowing physicians to get better information faster, thus potentially allowing physicians to deliver treatment sooner.
A Connected World
The challenge faced by modern-day clinicians of treating patients quickly and accurately is compounded by today’s Internet of Things (IoT) connected world and the massive volumes of data they are now receiving. Physicians depend on companies like Medicomp to sift through data—not only for cardiac monitoring, but for other key physiological health factors -- a significant, value-added remote monitoring service that Medicomp can bring to its clients.
“The ability to review multiple physiological measurements over a common time axis in a single report could greatly reduce the time required to diagnose and treat the patient. That is not only very important to Medicomp, but to all of healthcare,” added Mr. Balda. Patients are anxious for answers but often fearful to engage highly-sophisticated technology.
Physicians will increasing rely on Medicomp in the consumer-connected healthcare world as it rapidly advances, particularly in the realm of the net of Things (IoT) and medical wearables
Medicomp understands the patients prefer devices that fit into their daily lives with convenience and ease. If the patient cannot or will not complete the procedure, the physician simply cannot treat what they cannot see, adding frustration and cost for everyone involved.
“Medicomp invested significantly in the TelePatch technology and the best compliment we received is from a patient that described TelePatch as simply, “forgettable,” Mr. Balda shared. “They just forgot they were wearing our monitor and were able to go about their daily life while the physician received the information.”
Dedicated to Research
Clinical trials are witnesses to cutting-edge technological advancement, paving paths for the future of diagnostics. Medicomp incorporates these advancements into the commercial world.
A large academic medical center recently completed the world’s largest atrial fibrillation clinical trial. Initially, study’s leaders were unable to find a cardiac monitoring company that could meet their specific requirements. Medicomp delivered an entirely customized end-to-end solution. After partnering exclusively with Medicomp, thousands of patients across multiple countries were processed over a 6-year period. Final publication is expected later this year.
Medicomp continues to invest in the advancement of medical technology with a commitment to advancing the science of remote patient monitoring. This focus will deliver easier-to-use technology encompassing additional physiological information - allowing doctors to diagnose patients faster and initiate better treatments. As the consumer-connected healthcare world continues to rapidly advance, Medicomp will continue to deliver technology and partner with companies across the globe to drive future innovation and efficiencies.
This content is copyright protected
However, if you would like to share the information in this article, you may use the link below: